Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000238814 | SCV000296958 | uncertain significance | not specified | 2015-08-10 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000238814 | SCV000711549 | likely benign | not specified | 2017-10-24 | criteria provided, single submitter | clinical testing | p.Gly460Ser in exon 9 of CACNA1D: This variant is not expected to have clinical significance due to a lack of conservation across species, including mammals. Of note, 23 mammals have a Serine (Ser) at this position despite high nearby amino acid conservation. In addition, computational prediction tools do not suggest a high likelihood of impact to the protein. It has also been identified in 46/126 640 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnom ad.broadinstitute.org; dbSNP rs35874056). ACMG/AMP Criteria applied: BS2 (Richar ds 2015). |
Genetic Services Laboratory, |
RCV000238814 | SCV002065320 | likely benign | not specified | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001854916 | SCV002306488 | likely benign | not provided | 2025-01-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001854916 | SCV002525339 | uncertain significance | not provided | 2024-10-31 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign in association with a CACNA1D-related disorder to our knowledge; This variant is associated with the following publications: (PMID: 30402224, 30365130) |